Patent · US Active

Vaccine formulations comprising saponin-containing adjuvants

US9107859B2 · kind B2 · utility

0Cited by
13References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 9, 2010
Grant dateAug 18, 2015
Priority date
Expiry dateSep 18, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/32134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified (crude extracts) or minimally purified. The emulsion of the present invention can act as vehicle for the delivery of a pharmaceutical composition comprising at least one immunogen and, in particular, an immunogen selected from the group consisting of an inactivated pathogen, an attenuated pathogen, a subunit, a recombinant expression vector, and a plasmid or combinations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.